Diabetes pill tested as new fix for dangerous low salt
NCT ID NCT04447911
Summary
This study is testing if a drug called empagliflozin, usually used for diabetes, can help raise low sodium levels in the blood. It will involve 172 hospitalized patients whose low sodium is linked to conditions like heart failure, liver disease, or a hormone imbalance (SIADH). Patients will receive either the drug or a placebo pill to see which one more effectively and safely corrects their sodium levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire Vaudois (CHUV)
RECRUITINGLausanne, Canton of Vaud, 1011, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Erasmus Universität Medisch Centrum Rotterdam, Department of Internal Medicine
RECRUITINGRotterdam, 3015, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kantonsspital Luzern
RECRUITINGLucerne, 6000, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Spitalzentrum Biel
RECRUITINGBiel, 2502, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Hospital Basel
RECRUITINGBasel, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital of Würzburg, med. Poliklinik
RECRUITINGWürzburg, 97080, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.